BiomX (PHGE) Cash & Current Investments (2018 - 2026)

BiomX has reported Cash & Current Investments for 9 years, with the latest figure at $493000.0 in Q1 2026.

• Quarterly Cash & Current Investments fell 97.66% year-over-year to $493000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $493000.0 (down 97.66% YoY) and the FY2025 annual result came in at $3.7 million, down 79.35% from the prior year.
• Cash & Current Investments slipped to $493000.0 in Q1 2026 per PHGE's latest filing, from $3.7 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $38.0 million in Q2 2022 and troughed at $493000.0 in Q1 2026.
• A 5-year average of $21.1 million and a median of $23.4 million in 2023 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2024: Cash & Current Investments rose 22.72% in 2022, then tumbled 97.81% in 2024.
• Over 5 years, Cash & Current Investments stood at $31.4 million in 2022, then plunged by 49.51% to $15.9 million in 2023, then gained by 12.29% to $17.8 million in 2024, then plunged by 79.35% to $3.7 million in 2025, then tumbled by 86.6% to $493000.0 in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $493000.0, $3.7 million, and $7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.